Works matching IS 01052896 AND DT 2008 AND VI 222 AND IP 1
Results: 24
Polarized immune responses differentially regulate cancer development.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 145, doi. 10.1111/j.1600-065X.2008.00600.x
- By:
- Publication type:
- Article
Engineering therapeutic monoclonal antibodies.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 9, doi. 10.1111/j.1600-065X.2008.00601.x
- By:
- Publication type:
- Article
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 162, doi. 10.1111/j.1600-065X.2008.00602.x
- By:
- Publication type:
- Article
Immunotherapy of malignant brain tumors.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 70, doi. 10.1111/j.1600-065X.2008.00603.x
- By:
- Publication type:
- Article
Twelve immunotherapy drugs that could cure cancers.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 357, doi. 10.1111/j.1600-065X.2008.00604.x
- By:
- Publication type:
- Article
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 316, doi. 10.1111/j.1600-065X.2008.00605.x
- By:
- Publication type:
- Article
Signaling defects in anti-tumor T cells.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 192, doi. 10.1111/j.1600-065X.2008.00606.x
- By:
- Publication type:
- Article
Cancer vaccines for established cancer: how to make them better?
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 242, doi. 10.1111/j.1600-065X.2008.00612.x
- By:
- Publication type:
- Article
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 155, doi. 10.1111/j.1600-065X.2008.00607.x
- By:
- Publication type:
- Article
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 180, doi. 10.1111/j.1600-065X.2008.00608.x
- By:
- Publication type:
- Article
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 206, doi. 10.1111/j.1600-065X.2008.00610.x
- By:
- Publication type:
- Article
Autoantibodies to tumor-associated antigens: reporters from the immune system.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 328, doi. 10.1111/j.1600-065X.2008.00611.x
- By:
- Publication type:
- Article
The flip side of immune surveillance: immune dependency.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 341, doi. 10.1111/j.1600-065X.2008.00609.x
- By:
- Publication type:
- Article
Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 117, doi. 10.1111/j.1600-065X.2008.00613.x
- By:
- Publication type:
- Article
The impact of T-cell immunity on ovarian cancer outcomes.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 101, doi. 10.1111/j.1600-065X.2008.00614.x
- By:
- Publication type:
- Article
Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 222, doi. 10.1111/j.1600-065X.2008.00615.x
- By:
- Publication type:
- Article
Multiple roles for CD4<sup>+</sup> T cells in anti-tumor immune responses.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 129, doi. 10.1111/j.1600-065X.2008.00616.x
- By:
- Publication type:
- Article
Reengineering dendritic cell-based anti-cancer vaccines.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 256, doi. 10.1111/j.1600-065X.2008.00617.x
- By:
- Publication type:
- Article
Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 287, doi. 10.1111/j.1600-065X.2008.00618.x
- By:
- Publication type:
- Article
Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 299, doi. 10.1111/j.1600-065X.2008.00619.x
- By:
- Publication type:
- Article
Strategies and challenges in eliciting immunity to melanoma.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 28, doi. 10.1111/j.1600-065X.2008.00620.x
- By:
- Publication type:
- Article
The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 277, doi. 10.1111/j.1600-065X.2008.00621.x
- By:
- Publication type:
- Article
Antigen-specific immunotherapy of cervical and ovarian cancer.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 43, doi. 10.1111/j.1600-065X.2008.00622.x
- By:
- Publication type:
- Article
Tumor immunology top 10 list.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 5, doi. 10.1111/j.1600-065X.2008.00623.x
- By:
- Publication type:
- Article